A triterpene derivative useful for the treatment of hepatic disorders is disclosed. This compound comprises as an active ingredient a triterpene derivative represented by the following formula (I) or a salt thereof: ##STR00001## wherein R.sup.1 represents a hydroxyl group, arylmethyloxy, lower alkoxy, or lower alkanoyloxy, R.sup.2 represents lower alkyl, lower alkenyl, --CH.sub.2OR.sup.5, formyl, --COOR.sup.6, or --CH.sub.2N(R.sup.7)R.sup.8, or R.sup.1 and R.sup.2 may combine with each other to form --O--C(R.sup.9)R.sup.10--O--CH.sub.2--, R.sup.3 and R.sup.4, which may be the same or different, represent a hydrogen atom, a hydroxyl group, lower alkyl, lower alkenyl, aryl, hydroxymethyl, --N(R.sup.11)R.sup.12, formyl, --COOR.sup.6, or --OR.sup.13, or R.sup.3 and R.sup.4 may combine with each other to form oxo, hydroxyimino, or alkylidene and X represents O, CH.sub.2, or NH.

 
Web www.patentalert.com

> Condensed indoline derivatives and their use as 5HT, in particular 5HT.sub.2c, receptor ligands

~ 00313